Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02122328 · ClinicalTrials.gov registry record · NA
Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome
A NA study of Twin Twin Transfusion Syndrome, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 642
- Enrollment target
- 1
- Study location
NCT02122328 is a NA study of Twin Twin Transfusion Syndrome that has completed, run by University of Southern California. The registered enrollment target is 642 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02122328, a NA study of Twin Twin Transfusion Syndrome, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 642 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that treatment of twin-twin transfusion syndrome (TTTS) using sequential laser photocoagulation of communicating vessels (SQLPCV) over the predominant method, selective laser photocoagulation of communicating vessels (SLPCV), may provide vascular stability to the donor fetus. The primary objective is to evaluate the perinatal outcome, specifically, donor intrauterine survival of TTTS managed by SQLPCV vs. SLPCV in a prospective, randomized trial.
Conditions Studied
Interventions
- PROCEDURE Sequential laser photocoagulation of communicating vessels.
- PROCEDURE Selective laser photocoagulation of communicating vessels
Study Locations (1)
California
- Hollywood Presbyterian Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 642 participants |
| Start Date | 2010-06-09 |
| Est. Completion | 2023-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02122328
The ClinicalTrials.gov registry entry for NCT02122328 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 642 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Twin Twin Transfusion Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Sequential laser photocoagulation of communicating vessels. is the first listed.
NCT02122328 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02122328 about?
NCT02122328 is a clinical study titled "Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome". The investigators hypothesize that treatment of twin-twin transfusion syndrome (TTTS) using sequential laser photocoagulation of communicating vessels (SQLPCV) over the predominant method, selective laser photocoagulation of communicating vessels (SLPCV), may provide vascular stability to the donor ...
What is the current status of trial NCT02122328?
This trial is currently completed. It is a NA study. The enrollment target is 642 participants. The study started on 2010-06-09. Estimated completion is 2023-10-31.
What conditions does trial NCT02122328 study?
This clinical trial studies the following conditions: Twin Twin Transfusion Syndrome.
What interventions are being tested in trial NCT02122328?
The interventions under investigation include: Sequential laser photocoagulation of communicating vessels. (PROCEDURE), Selective laser photocoagulation of communicating vessels (PROCEDURE).
Who is sponsoring clinical trial NCT02122328?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02122328 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Twin Twin Transfusion Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.